Highlights - Industry would start looking for supplies from Mid-March - This means Chinese production re-start is eagerly awaited now - Impact expected across the board with very few exceptions - Large API manufacturers also expected to be adversely impacted - Backward integrated plays with ready capacity can capitalize opportunity The Indian pharma industry sources about 50 percent of products in volume terms from China. About, 57 APIs (active pharmaceutical ingredients) of antibiotics, vitamins and steroids can go out of stock in case of a prolonged shutdown in China due...
Moneycontrol Pro Panorama | Global diversification and its side effects
Feb 7, 2023 / 02:10 PM IST
In today’s edition of Moneycontrol Pro Panorama: IT slowdown likely to get tougher, a glimmer of hope for rural jobs, central ba...
Read NowMoneycontrol Pro Weekender: The elephant in the room
Feb 4, 2023 / 11:20 AM IST
The well-crafted and well-delivered budget got many ‘wows’, but Mr Market’s worry lines are not yet gone
Read NowTo read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Sharpest Opinions
Access to 230+ exclusive stories per month from our editorial and Experts
+
Have a Global edge with access to content from world renowned experts and journalist
Actionable Insights
Access to 40+ weekly investment ideas including 4 daily technical calls
Virtual Events
Exclusive access to live webinars from market experts on trading and investment strategies
Newsletters
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers